These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Laudanna C; Alon R Thromb Haemost; 2006 Jan; 95(1):5-11. PubMed ID: 16543955 [TBL] [Abstract][Full Text] [Related]
6. Necessity is the mother of invention: an ingenious method for leukocyte-targeted delivery of siRNA in stabilized nanoparticles demonstrates a role of cyclin D1 in inflammation. Kakuta H ChemMedChem; 2008 Jul; 3(7):1024-5. PubMed ID: 18465763 [No Abstract] [Full Text] [Related]
7. Pathophysiology of leukocyte-tissue interactions. Molteni R; Fabbri M; Bender JR; Pardi R Curr Opin Cell Biol; 2006 Oct; 18(5):491-8. PubMed ID: 16904306 [TBL] [Abstract][Full Text] [Related]
8. Hepcidin activation during inflammation: make it STAT. Fleming RE Gastroenterology; 2007 Jan; 132(1):447-9. PubMed ID: 17241894 [No Abstract] [Full Text] [Related]
9. Atherosclerosis-underlying inflammatory mechanisms and clinical implications. Patel S; Celermajer DS; Bao S Int J Biochem Cell Biol; 2008; 40(4):576-80. PubMed ID: 18203647 [TBL] [Abstract][Full Text] [Related]
10. New approaches to blockade of alpha4-integrins, proven therapeutic targets in chronic inflammation. Kummer C; Ginsberg MH Biochem Pharmacol; 2006 Nov; 72(11):1460-8. PubMed ID: 16870156 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which fatty acids regulate leucocyte function. Martins de Lima T; Gorjão R; Hatanaka E; Cury-Boaventura MF; Portioli Silva EP; Procopio J; Curi R Clin Sci (Lond); 2007 Jul; 113(2):65-77. PubMed ID: 17555405 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoids for the treatment of inflammation. Ashton JC Curr Opin Investig Drugs; 2007 May; 8(5):373-84. PubMed ID: 17520866 [TBL] [Abstract][Full Text] [Related]
13. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Nilsson BO Inflamm Res; 2007 Jul; 56(7):269-73. PubMed ID: 17659431 [TBL] [Abstract][Full Text] [Related]
14. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Wong ET; Tergaonkar V Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055 [TBL] [Abstract][Full Text] [Related]
15. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more. Barberis L; Hirsch E Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175 [TBL] [Abstract][Full Text] [Related]
16. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Woodfin A; Voisin MB; Nourshargh S Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2514-23. PubMed ID: 17872453 [TBL] [Abstract][Full Text] [Related]
17. Altered protease signalling in the gut: a novel pathophysiological factor in irritable bowel syndrome. Róka R; Wittmann T; Bueno L Neurogastroenterol Motil; 2008 Aug; 20(8):853-6. PubMed ID: 18710475 [No Abstract] [Full Text] [Related]
18. RAGE in inflammation: a new therapeutic target? Bierhaus A; Stern DM; Nawroth PP Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586 [TBL] [Abstract][Full Text] [Related]
19. [Screening of bioactive metabolites that suppress inflammation]. Umezawa K Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1685-9. PubMed ID: 18051400 [No Abstract] [Full Text] [Related]